publication date: Nov. 17, 2017

Defining the next level for Inova

Second story in a three-part series

By Paul Goldberg

In 2010, John Knox Singleton, the CEO of the Inova Health System, had several meetings with John Niederhuber, a surgeon and scientist who had just been replaced as NCI director.

At the time, Niederhuber still had a lab at NIH, but was plotting the next step in his career. Singleton had been Inova’s CEO since 1984.

“He was picking my brain about where is healthcare going, what is this personalized medicine, what is genomics and genetics, and how is it going to impact healthcare, if at all,” Niederhuber recalled recently.

Niederhuber was impressed by the questions raised by the man who grew a sleepy little Fairfax Hospital into a major regional health system. The Inova Health System has revenues of $2.7 billion. It employs over 17,000 people.

Singleton wanted to know what it would take to reach the next level, to become more competitive with Johns Hopkins to the north and Duke to the south.

“And I thought that was an interesting set of bookends,” Niederhuber recalled.

This was a challenging time for Inova. The hospital had just failed in its effort to take over the Sibley Hospital … Continue reading Defining the next level for Inova

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2018 The Cancer Letter Inc.